Katie Couric and Paula Schneider: Sharing Cancer Journeys One Letter At a Time
Patients with Cancer Stand to Lose if Supreme Court Repeals ‘Obamacare’
Learning the Ins and Outs of Metastatic Breast Cancer
Patient Inhibitions A Significant Barrier to Colon Cancer Screening
October 30th 2020, 6:00pm
By Dr. Anthony Lucci
A breast surgical oncologist at The University of Texas MD Anderson Cancer Center notes that while breast cancer screening can be delayed a few months, it should not be skipped altogether.
October 30th 2020, 4:00pm
By Bonnie Annis
2020 has been a challenging year, especially for survivors and those with cancer, but you can look forward to the new year. You just have to imagine the possibilities.
October 30th 2020, 3:00pm
By Conor Killmurray
Two sisters diagnosed with the same stage of breast cancer in the same spot three weeks apart take part in proton therapy trial, Mayo Clinic and Google Health partner to investigate the use of artificial intelligence in assisting with radiotherapy treatments and more from the weekly roundup of news and research happening in the cancer landscape.
October 30th 2020, 1:00pm
By Arlene Weintraub
Ultra-precise drug targeting brings new hope for patients with non-small cell lung cancer that harbors rare mutations.
October 29th 2020, 9:00pm
By Beth Fand Incollingo
Giving fewer courses of chemotherapy and no radiation could become a new standard for patients with stage 1 or 2 diffuse large B cell lymphoma based on the results of a recent study.
October 29th 2020, 6:00pm
By Ryan McDonald
Here is a list of some recent trials that launched within the cancer space in October.
October 29th 2020, 4:00pm
By Felicia Mitchell
Using the full use of my left hand for a few months, I relied more on my lymphedema limb. Those with lymphedema, I learned, might do well to avoid fractures as best they can.
October 29th 2020, 1:00pm
By Darlene Dobkowski, MA
As colorectal cancer is becoming more prevalent in younger patients, the U.S. Preventive Services Task Force (USPSTF) introduced a draft recommendation that, if accepted, will lower the screening age from 50 years to 45 years in those with average risk.
October 28th 2020, 9:00pm
By Jessica Skarzynski
5-year follow up data from a promising trial shows survival benefits with the combination treatment of Tafinlar and Mekinist with patients with melanoma.
October 28th 2020, 6:00pm
A study assessing the value of movement found that it improved physical and mental health in older adults who had survived cancer, as well as those with no history of the disease.
